These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 10761804

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Antiarrhythmic effects of selective prolongation of refractoriness. Electrophysiologic actions of sematilide HCl in humans.
    Sager PT, Nademanee K, Antimisiaris M, Pacifico A, Pruitt C, Godfrey R, Singh BN.
    Circulation; 1993 Sep; 88(3):1072-82. PubMed ID: 8353869
    [Abstract] [Full Text] [Related]

  • 3. The efficacy, electrophysiologic and electrocardiographic effects of intravenous pirmenol, a new class I antiarrhythmic agent, in patients with ventricular tachycardia: comparison with procainamide.
    Gold RL, Frumin H, Haffajee CI, Kerin NZ, Jarandilla R.
    Pacing Clin Electrophysiol; 1988 Mar; 11(3):308-14. PubMed ID: 2452418
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Procainamide-induced changes in reentrant ventricular tachycardia with special reference to the tachycardia-interrupting critical paced cycle length during transient entrainment with rapid pacing.
    Aizawa Y, Naitoh N, Washizuka T, Kitazawa H, Takahashi K, Kodama I, Shibata A.
    Jpn Heart J; 1994 Sep; 35(5):611-23. PubMed ID: 7830326
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Differential effects of isoproterenol on sustained ventricular tachycardia before and during procainamide and quinidine antiarrhythmic drug therapy.
    Markel ML, Miles WM, Luck JC, Klein LS, Prystowsky EN.
    Circulation; 1993 Mar; 87(3):783-92. PubMed ID: 8443899
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Prospective comparison of intravenous quinidine and intravenous procainamide in patients undergoing electrophysiologic testing.
    Holzberger PT, Greenberg ML, Paicopolis MC, Ozahowski TP, Ho PC, O'Connor GT.
    Am Heart J; 1998 Jul; 136(1):49-56. PubMed ID: 9665218
    [Abstract] [Full Text] [Related]

  • 14. Prediction of antiarrhythmic efficacy of class I and III agents in patients with ventricular tachycardia by signal-averaged ECG analysis.
    Kulakowski P, Bashir Y, Heald S, Paul V, Anderson MH, Gibson S, Malik M, Camm AJ.
    Pacing Clin Electrophysiol; 1992 Nov; 15(11 Pt 2):2116-21. PubMed ID: 1279610
    [Abstract] [Full Text] [Related]

  • 15. The effects of beta-adrenergic stimulation on the frequency-dependent electrophysiologic actions of amiodarone and sematilide in humans.
    Sager PT, Follmer C, Uppal P, Pruitt C, Godfrey R.
    Circulation; 1994 Oct; 90(4):1811-9. PubMed ID: 7923666
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Electropharmacologic testing in sustained ventricular tachycardia associated with coronary heart disease: value of the response to intravenous procainamide in predicting the response to oral procainamide and oral quinidine treatment.
    Oseran DS, Gang ES, Rosenthal ME, Mandel WJ, Peter T.
    Am J Cardiol; 1985 Nov 15; 56(13):883-6. PubMed ID: 3904387
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of an open-loop, computer-based infusion system designed to achieve a series of constant, targeted plasma procainamide concentrations in patients undergoing electrophysiologic testing.
    Coyle JD, Carnes CA, Schaal SF.
    Pharmacotherapy; 1997 Nov 15; 17(3):445-56. PubMed ID: 9165549
    [Abstract] [Full Text] [Related]

  • 20. Use-dependent prolongation of ventricular tachycardia cycle length by type I antiarrhythmic drugs in humans.
    Kidwell GA, Greenspon AJ, Greenberg RM, Volosin KJ.
    Circulation; 1993 Jan 15; 87(1):118-25. PubMed ID: 8418998
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.